Motif Bio plc (AIM:MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has been selected to present at BIO-Europe, a leading European pharmaceutical-biotechnology conference. The CEO of Motif, Graham Lumsden, will present.
Presentation dates:
The BIO-Europe 2015 conference on November 2 through November 4, 2015 at the International Congress Center (ICM) in Munich, Germany. Motif will be presenting at 16:45 CET on November 3 in Room 2, Level 0.
For further information please contact
Enquiries:
Motif Bio plc
Graham Lumsden (Chief Executive Officer)
David Huang (Chief Medical Officer)
www.motifbio.com
info@motifbio.com
Zeus Capital Limited (NOMINATED ADVISER and BROKER)
Phil Walker/Dan Bate
Dominic Wilson
+44 (0) 20 3829 5000
Northland Capital Partners Limited (BROKER)
Patrick Claridge/ David Hignell
John Howes/ Mark Treharne (Broking)
+44 (0) 20 7382 1100
MC Services AG (TRADE PR)
Raimund Gabriel
Shaun Brown
+49 (0) 89 210 2280
+44 (0) 207 148 5998
Plumtree Capital Limited (FINANCIAL ADVISOR)
Stephen Austin
+44 (0) 207 183 2493
Yellow Jersey PR Limited (FINANCIAL PR)
Charles Goodwin
Dominic Barretto
Help employers find you! Check out all the jobs and post your resume.
